| Name | LY2955303 |
|---|---|
| Synonyms |
4-[5-[3,5-Bis(1,1-dimethylethyl)phenyl]-1-[4-[(4-methyl-1-piperazinyl)carbonyl]phenyl]-1H-pyrazol-3-yl]benzoic acid
inhibit,LY 2955303,Autophagy,LY-2955303,Retinoic acid rectors,R/RXR,Inhibitor,LY2955303,Retinoid X rectors LY2955303 >= (HPLC) LY2955303; LY-2955303; LY Benzoic acid, 4-[5-[3,5-bis(1,1-dimethylethyl)phenyl]-1-[4-[(4-methyl-1-piperazinyl)carbonyl]phenyl]-1H-pyrazol-3-yl] |
| Description | LY2955303 is a potent and selective retinoic acid receptor gamma (RARγ) antagonist with a Ki of 1.09 nM. |
|---|---|
| Related Catalog | |
| Target |
Ki: 1.09 nM (RARγ)[1] |
| In Vitro | LY2955303 is tested and observed that the binding Kis for RARα, RARβ and RARγ are >1700, >2980 and 1.09 nM, respectively. The functional Ki for RARγ is 7.1±4.9 nM[1]. |
| In Vivo | A single oral dose of LY2955303 demonstrates a dose responsive effect whereby the rat reduces differential weight bearing (ED50=0.72 mg/kg)[1]. |
| References |
| Molecular Formula | C36H42N4O3 |
|---|---|
| Molecular Weight | 578.74 |
| Storage condition | 2-8℃ |
| Hazard Codes | Xn |
|---|